4AB
AbbVie, Inc. · HAN:4AB
261.20 EUR−0.8000 −0.31%
AbbVie, Inc. (HAN:4AB) last traded at 261.20 EUR, down 0.31% on the day. Over the past year the stock is up 13.66%. Its 52-week range is 229.60 to 262.00. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open261.40
Day range261.00 – 261.70
52-week range229.60 – 262.00
Volume0
Average volume (10 days)0
Market cap (USD)521.11 B
P/E50.86
EPS (TTM) (USD)5.82
Dividend yield2.35%
Beta (1 year)0.0129
Revenue (TTM) (USD)66.01 B
Employees57.00 K
Performance
+3.04%1 week
+13.66%1 month
+13.66%3 months
+13.66%6 months
+13.66%Year to date
+13.66%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology TransitionGuruFocus · 02 Nov 2026
- AbbVie Price Target Raised to $346.00/Share From $310.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
- Morgan Stanley maintains AbbVie at Overweight, raises price target to $346 from $310TradingView · 02 Nov 2026
- AbbVie Price Target Raised to $322.00/Share From $288.00 by GuggenheimDow Jones Newswires · 02 Nov 2026
- Guggenheim maintains AbbVie at Buy, raises price target to $322 from $288TradingView · 02 Nov 2026
- Brise Pharmaceuticals Announces Global License Agreement With Abbvie To Advance The Next-Generation Of Migraine TherapiesReuters · 02 Nov 2026
- ABBV Q3 Earnings Call Highlights Raised Outlook and Pipeline ProgressZacks · 02 Nov 2026
- AbbVie Price Target Raised to $340.00/Share From $300.00 by Wells FargoDow Jones Newswires · 02 Nov 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.